-
How 3 major ASC groups grew in orthopedics in 2024
Care is increasingly moving to the outpatient setting for several key specialties, including orthopedics. -
The most dangerous trends in orthopedics
From a distrust of the medical profession to reimbursements making it difficult for practices to sustain themselves, orthopedic surgeons are up against several barriers in 2025. -
UMN orthopedic surgeon dies at 94
University of Minnesota orthopedic surgeon Ramon Gustilo, MD, has died at 94, according to a Feb. 7 report from The Minnesota Star Tribune. -
AAOS honors 4 surgeons for research
The American Academy of Orthopaedic Surgeons honored four orthopedic surgeons for their research work. -
Medicare ASC payments for total joint replacements to grow in 2025
CMS' ASC reimbursements are expected to increase this year for several procedures including orthopedic care, according to VMG's "ASCs in 2024: A Year in Review" report. -
Woman tentatively settles lawsuit against Kerlan-Jobe Surgery Center
A woman who sued Los Angeles-based Kerlan-Jobe Surgery Center claiming its practices "prioritized profit over care" and retaliation reached a tentative settlement, My News LA reported Feb. 6. -
TriMed launches wrist fixation system
Valencia, Calif.-based TriMed has launched its Wrist Fixation System 3 to treat distal radius fractures. -
Zimmer Biomet's Q4 sales grow 4.3%: 4 notes
Zimmer Biomet saw net sales grow 4.3% year over year in the fourth quarter of 2024, according to financial results posted Feb. 6. -
CentraCare, University of Minnesota Physicians partnership expands to hospital
CentraCare and the University of Minnesota Physicians' partnership is expanding their orthopedic program to Monticello (Minn.) Hospital. -
Top 10 Strategic Partnership Recommendations for Orthopedic & Spine Groups in 2025
The Journal of Orthopaedic Innovation and Experience has published a must-read article, "Consolidation and Strategic Partnerships for Orthopaedic Groups: Trends for 2025 and Practical Recommendations for Success." This in-depth piece explores the latest consolidation trends and provides 10 key recommendations to help groups assess whether a strategic partnership is the right move for their future in today’s challenging financial and operational landscape. -
OrthoArkansas taps president
Little Rock-based OrthoArkansas has tapped orthopedic surgeon Kirk Reynolds, MD, as its new president. -
Hospital for Special Surgery names 1st medical advisor for strategy, business development
Mark Bowen, MD, is New York City-based Hospital for Special Surgery's inaugural medical advisor, strategy and business development. -
Tallahassee Orthopedic Clinic taps CEO
Tallahassee (Fla.) Orthopedic Clinic has appointed Kelby Tardi as its new CEO following the departure of Michael Boblitz. -
OrthoGeorgia earns total joint replacement, complex spine certification
Macon-based OrthoGeorgia has earned accreditation from the Accreditation Association for Ambulatory Health Care for total joint replacement and complex spine care. -
Employment vs. private practice: 7 orthopedic leaders weigh in
From less independence to higher pay, physicians often have to make several tradeoffs when deciding between employment and private practice. -
Louisiana orthopedic group to add 4 physicians
Baton Rouge (La.) Orthopaedic Clinic is adding four surgeons in April. -
7 spine, orthopedic surgery firsts
Since November several spine and orthopedic innovations made their debut at practices and health systems. -
Crovetti Orthopaedics adds sports medicine physician
Las Vegas-based Crovetti Orthopaedics added Bradley Greenbaum, MD, according to a Feb. 3 news release. -
United Football League taps medical director
The United Football League, a professional high-level minor league that was created following the merger of the XFL and United States Football League, has named Damond Blueitt, MD, as its medical director. -
2 orthopedic surgeons call for more study of Ozempic
As millions of Americans have turned to GLP-1 medications to lose weight, studies and specialists alike have expressed differing opinions on their safety, efficacy and likeliness to have any impact on the musculoskeletal industry.
Page 1 of 50